ER
PTVE icon

EVR Research’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

EVR Research’s Portfolio PTVE Stock Details PTVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-641,444
Closed -$8.79M – 43
2023
Q4 		$8.79M Sell
641,444
-1,118,556
-64% -$11.8M 1.97% 19
2023
Q3 		$14.3M Buy
1,760,000
+160,000
+10% +$1.31M 3.79% 11
2023
Q2 		$12.1M Sell
1,600,000
-20,000
-1% -$153K 3.24% 15
2023
Q1 		$13M Buy
1,620,000
+75,000
+5% +$771K 3.23% 14
2022
Q4 		$17.6M Sell
1,545,000
-225,000
-13% -$2.45M 5.29% 6
2022
Q3 		$15.5M Buy
1,770,000
+587,441
+50% +$6.1M 4.58% 8
2022
Q2 		$11.8M Buy
1,182,559
+648,192
+121% +$6.53M 3.48% 11
2022
Q1 		$5.38M Sell
534,367
-193,633
-27% -$2.06M 1.98% 21
2021
Q4 		$9.23M Buy
728,000
+1,000
+0.1% +$13K 4.31% 12
2021
Q3 		$9.1M Buy
727,000
+302,000
+71% +$4.1M 5.05% 7
2021
Q2 		$6.41M Buy
425,000
+140,000
+49% +$2.1M 3.72% 10
2021
Q1 		$3.92M Buy
+285,000
New +$4.42M 2.98% 14

Other funds holding PTVE

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

EVR Research's PTVE Position: Q1 2024 in Review

EVR Research sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q1 2024, closing a stake of 641,444 shares — an estimated $8.79M sold.

EVR Research first reported a position in PTVE in Q1 2021 and held it in 12 quarters. The position peaked at $17.6M in Q4 2022. 148 funds tracked by Wall St. Rank hold PTVE as of Q1 2024.

  • EVR Research reported no remaining Pactiv Evergreen Inc. Common stock position as of Q1 2024 after selling out during the quarter.
  • EVR Research sold 641,444 Pactiv Evergreen Inc. Common stock shares in Q1 2024, an estimated $8.79M.
  • EVR Research first reported a position in Pactiv Evergreen Inc. Common stock in Q1 2021 and held it in 12 quarters.
  • EVR Research's Pactiv Evergreen Inc. Common stock position peaked at $17.6M in Q4 2022.
  • 148 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q1 2024.

Based on EVR Research's 13F filing for Q1 2024, filed 15 May 2024.